Free Trial
→ Critical AI announcement set to ignite AI 2.0 (From Timothy Sykes) (Ad) Free OPY Stock Alerts

Oppenheimer (OPY) Financials

Oppenheimer logo
$72.06 +0.78 (+1.09%)
As of 03:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Oppenheimer

Annual Income Statements for Oppenheimer

This table shows Oppenheimer's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 8.83 1.96 -1.16 23 29 53 123 159 32 30 72
Consolidated Net Income / (Loss)		 9.56 2.90 0.49 23 29 53 123 159 32 30 71
Net Income / (Loss) Continuing Operations		 5.06 -2.83 -9.63 22 29 53 123 159 32 30 71
Total Pre-Tax Income 		17 -2.43 -22 20 45 75 169 225 46 47 106
Total Revenue		 981 898 858 920 912 988 1,183 1,384 1,111 1,249 1,432
Net Interest Income / (Expense)		 0.00 0.00 36 77 122 122 18 27 61 105 136
Total Interest Income		 0.00 0.00 36 77 169 168 33 36 61 105 136
Investment Securities Interest Income		 - - - - 52 51 33 36 61 105 136
Total Interest Expense		 0.00 0.00 0.00 0.00 46 46 16 9.86 0.00 0.00 0.00
Total Non-Interest Income		 981 898 821 843 790 865 1,165 1,358 1,050 1,144 1,297
Trust Fees by Commissions		 470 418 377 337 330 320 395 402 370 349 410
Service Charges on Deposit Accounts		 - - - - - - 35 16 105 173 139
Other Service Charges		 29 33 26 36 16 35 30 29 1.11 24 34
Investment Banking Income		 407 383 350 399 430 480 678 887 553 533 660
Other Non-Interest Income		 75 64 68 72 14 30 28 24 21 65 55
Total Non-Interest Expense		 964 900 880 901 867 913 1,014 1,160 1,065 1,202 1,327
Salaries and Employee Benefits		 654 611 585 602 607 658 771 887 741 782 937
Net Occupancy & Equipment Expense		 129 129 131 133 136 144 144 141 145 157 163
Other Operating Expenses		 180 160 164 166 124 111 99 132 179 262 227
Income Tax Expense		 12 0.41 -12 -2.13 16 22 46 66 13 16 35
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.74 0.94 1.65 - - - 0.00 0.00 -0.24 0.09 -0.31
Basic Earnings per Share		 $1.00 $0.14 ($0.09) $2.00 $2.18 $4.10 $9.73 $12.57 $2.77 $2.81 $6.91
Weighted Average Basic Shares Outstanding		 13.60M 13.64M 13.37M 13.25M 13.25M 12.90M 12.64M 12.64M 11.67M 10.74M 10.35M
Diluted Earnings per Share		 $0.62 $0.14 ($0.09) $2.00 $2.05 $3.82 $9.30 $11.70 $2.57 $2.59 $6.37
Weighted Average Diluted Shares Outstanding		 14.25M 13.64M 13.37M 13.67M 14.06M 13.85M 13.22M 13.58M 12.61M 11.65M 11.23M
Weighted Average Basic & Diluted Shares Outstanding		 13.60M 14M 12.90M 13.24M 13.30M 13.09M 0.00 0.00 0.00 0.00 0.00
Cash Dividends to Common per Share		 $0.44 $440.00 $440.00 $1.32 $0.88 $0.46 $1.48 $1.54 $0.60 $0.60 $0.66

Quarterly Income Statements for Oppenheimer

This table shows Oppenheimer's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 22 15 -9.40 14 11 26 10 25 11 31 22
Consolidated Net Income / (Loss)		 22 14 -9.57 14 12 26 10 25 11 31 22
Net Income / (Loss) Continuing Operations		 22 14 -9.57 14 12 26 10 25 11 31 22
Total Pre-Tax Income 		30 19 -12 22 18 37 16 35 17 41 32
Total Revenue		 327 309 289 313 339 353 331 373 418 368 373
Net Interest Income / (Expense)		 35 12 9.85 26 56 27 35 38 78 36 38
Total Interest Income		 22 25 27 26 26 27 35 38 36 36 38
Investment Securities Interest Income		 22 25 27 26 26 27 35 38 36 36 38
Total Interest Expense		 -13 13 17 0.00 -31 0.00 0.00 0.00 -43 0.00 0.00
Total Non-Interest Income		 292 297 279 286 282 326 296 335 339 331 335
Trust Fees by Commissions		 88 87 89 84 90 96 97 103 114 111 110
Service Charges on Deposit Accounts		 50 49 44 42 38 37 35 35 32 30 29
Other Service Charges		 9.43 9.13 9.02 -2.27 7.65 10 7.49 9.18 7.02 5.10 13
Investment Banking Income		 134 139 121 145 128 165 146 174 174 176 169
Other Non-Interest Income		 11 13 16 17 19 18 10 14 12 8.98 15
Total Non-Interest Expense		 296 289 300 291 321 316 315 338 401 326 341
Salaries and Employee Benefits		 198 206 187 196 193 222 221 238 256 227 239
Net Occupancy & Equipment Expense		 37 38 39 40 40 40 40 41 42 42 42
Other Operating Expenses		 62 45 74 56 88 54 54 59 103 57 60
Income Tax Expense		 7.89 4.59 -2.13 7.81 6.24 12 5.60 11 6.34 11 11
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.03 -0.15 -0.17 -0.08 0.50 -0.31 0.00 0.00 - 0.00 0.00
Basic Earnings per Share		 $1.94 $1.32 ($0.85) $1.32 $1.02 $2.50 $0.99 $2.38 $1.04 $2.93 $2.06
Weighted Average Basic Shares Outstanding		 11.67M 11.09M 11.02M 10.52M 10.74M 10.41M 10.33M 10.33M 10.35M 10.47M 10.52M
Diluted Earnings per Share		 $1.83 $1.22 ($0.85) $1.21 $1.01 $2.37 $0.92 $2.16 $0.92 $2.72 $1.91
Weighted Average Diluted Shares Outstanding		 12.61M 11.96M 11.02M 11.44M 11.65M 11.00M 11.11M 11.28M 11.23M 11.28M 11.35M
Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Dividends to Common per Share		 - $0.15 $0.15 $0.15 - $0.15 $0.15 $0.18 - $0.18 $0.18

Annual Cash Flow Statements for Oppenheimer

This table details how cash moves in and out of Oppenheimer's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -34 -0.44 1.55 -17 43 -11 -44 306 -204 -109 4.32
Net Cash From Operating Activities		 78 -19 -67 -16 169 79 -54 228 64 -19 -108
Net Cash From Continuing Operating Activities		 78 -19 -67 -16 169 79 -54 228 64 -19 -108
Net Income / (Loss) Continuing Operations		 9.56 2.90 0.49 23 29 53 123 159 32 30 71
Consolidated Net Income / (Loss)		 9.56 2.90 0.49 23 29 53 123 159 32 30 71
Provision For Loan Losses		 0.00 0.12 -1.75 -0.03 0.12 -0.44 -0.04 2.90 -2.96 -0.01 -0.14
Depreciation Expense		 7.70 7.20 6.80 5.70 6.87 7.64 8.14 7.99 7.61 9.92 11
Amortization Expense		 19 14 15 12 13 13 37 40 41 43 45
Non-Cash Adjustments to Reconcile Net Income		 11 7.12 -14 11 -75 47 38 30 21 23 49
Changes in Operating Assets and Liabilities, net		 31 -51 -73 -68 194 -41 -260 -12 -34 -126 -284
Net Cash From Investing Activities		 -4.40 -5.89 40 -3.87 -8.19 -8.30 -3.94 -6.27 -14 -16 -3.84
Net Cash From Continuing Investing Activities		 -4.40 -5.89 40 -3.87 -8.19 -8.30 -3.94 -6.27 -14 -16 -3.84
Purchase of Property, Leasehold Improvements and Equipment		 -4.40 -5.89 -5.73 -5.61 -8.67 -10 -4.53 -8.27 -16 -17 -5.15
Purchase of Investment Securities		 - - 0.00 0.00 - - - 0.00 0.00 -2.93 -2.35
Sale and/or Maturity of Investments		 - 0.00 0.00 1.74 0.88 1.72 0.59 2.00 2.17 4.42 3.66
Net Cash From Financing Activities		 -108 25 29 3.24 -118 -82 14 85 -254 -75 116
Net Cash From Continuing Financing Activities		 -108 25 29 3.24 -118 -82 14 85 -254 -75 116
Issuance of Common Equity		 0.19 0.00 0.00 0.03 0.07 0.08 0.06 127 0.13 0.08 0.06
Repayment of Debt		 -45 0.00 0.00 -151 0.00 -50 -154 -0.02 -11 -1.00 -113
Repurchase of Common Equity		 0.00 -8.25 -3.94 -7.46 -5.89 -8.40 -15 -7.74 -61 -35 -9.60
Payment of Dividends		 -5.98 -6.01 -12 -8.28 -6.21 -5.94 -19 -19 -7.04 -6.45 -6.85
Other Financing Activities, Net		 -58 39 44 -30 -106 -18 76 -15 -175 -32 246
Cash Interest Paid		 19 17 20 24 54 41 19 10 23 68 89
Cash Income Taxes Paid		 7.59 6.09 5.01 2.38 12 17 11 62 38 21 21

Quarterly Cash Flow Statements for Oppenheimer

This table details how cash moves in and out of Oppenheimer's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 -27 -82 -0.95 1.77 -28 -1.17 5.55 -0.97 0.91 3.55 0.92
Net Cash From Operating Activities		 148 -86 -65 67 65 -79 -115 11 75 -92 40
Net Cash From Continuing Operating Activities		 148 -86 -65 67 65 -79 -115 11 75 -92 40
Net Income / (Loss) Continuing Operations		 22 14 -9.57 14 12 26 10 25 11 31 22
Consolidated Net Income / (Loss)		 22 14 -9.57 14 12 26 10 25 11 31 22
Provision For Loan Losses		 -3.02 -0.00 0.00 0.02 -0.02 0.00 -0.13 -0.01 -0.01 -0.01 0.00
Depreciation Expense		 1.89 1.88 2.02 2.69 3.34 2.64 2.74 2.74 2.72 2.79 2.74
Amortization Expense		 10 11 11 11 11 11 11 12 11 11 11
Non-Cash Adjustments to Reconcile Net Income		 28 6.52 -4.77 12 9.51 -1.51 13 15 17 5.16 8.98
Changes in Operating Assets and Liabilities, net		 88 -119 -63 27 30 -117 -152 -42 34 -141 -4.52
Net Cash From Investing Activities		 -3.70 -2.98 -6.20 -1.13 -5.25 -0.26 -1.16 1.87 -4.29 -0.36 -0.90
Net Cash From Continuing Investing Activities		 -3.70 -2.98 -6.20 -1.13 -5.25 -0.26 -1.16 1.87 -4.29 -0.36 -0.90
Purchase of Property, Leasehold Improvements and Equipment		 -4.68 -3.53 -6.20 -2.74 -4.59 -0.26 -1.41 -0.22 -3.26 -1.68 -1.13
Sale and/or Maturity of Investments		 0.98 0.56 - 1.61 2.26 0.00 0.25 2.09 1.32 1.32 0.23
Net Cash From Financing Activities		 -171 7.03 70 -64 -88 78 122 -14 -70 96 -38
Net Cash From Continuing Financing Activities		 -171 7.03 70 -64 -88 78 122 -14 -70 96 -38
Repurchase of Common Equity		 -1.08 -3.69 -3.60 -24 -3.88 -8.38 -0.93 -0.29 - -0.09 -0.58
Payment of Dividends		 -1.61 -1.67 -1.65 -1.58 -1.55 -1.58 -1.55 -1.86 -1.86 -1.90 -1.89
Other Financing Activities, Net		 -157 13 75 -38 -83 88 124 -12 45 98 -36
Cash Interest Paid		 8.63 14 16 22 17 21 20 25 22 21 1.34
Cash Income Taxes Paid		 12 4.24 16 0.34 -0.09 0.77 12 1.36 7.37 0.29 24

Annual Balance Sheets for Oppenheimer

This table presents Oppenheimer's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 2,787 2,698 2,237 2,439 2,240 2,465 2,714 3,043 2,714 2,875 3,383
Cash and Due from Banks		 64 63 65 48 91 80 35 214 112 29 33
Trading Account Securities		 1,151 991 769 969 906 848 694 702 576 880 1,207
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 57 63 68
Loans and Leases		 - - - - - - - - 57 63 68
Customer and Other Receivables		 899 873 877 889 765 797 1,157 1,275 1,203 1,060 1,269
Premises and Equipment, Net		 30 28 27 27 29 31 28 28 37 44 38
Goodwill		 138 138 138 138 138 138 138 138 138 142 144
Intangible Assets		 32 32 32 32 32 32 32 32 32 34 36
Other Assets		 456 573 328 335 280 539 630 526 533 623 588
Total Liabilities & Shareholders' Equity		 2,787 2,698 2,237 2,439 2,240 2,465 2,714 3,043 2,714 2,875 3,383
Total Liabilities		 2,254 2,173 1,724 1,915 1,695 1,872 2,028 2,090 1,894 2,086 2,532
Short-Term Debt		 1,597 1,411 1,049 1,184 1,110 1,143 1,105 1,156 1,167 1,372 1,543
Other Short-Term Payables		 - 258 242 266 255 - 298 342 239 256 331
Long-Term Debt		 209 249 295 317 214 150 206 194 113 113 252
Other Long-Term Liabilities		 447 255 137 148 116 580 419 398 374 345 406
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 534 525 513 524 545 593 686 825 795 789 850
Total Preferred & Common Equity		 528 518 511 524 545 593 686 823 794 789 850
Total Common Equity		 528 518 511 524 545 593 686 823 794 789 850
Common Stock		 108 102 101 95 95 94 81 78 29 32 30
Retained Earnings		 421 417 410 427 450 497 601 741 764 756 820
Accumulated Other Comprehensive Income / (Loss)		 -0.92 -0.90 -0.68 1.58 0.17 1.76 3.45 4.23 1.42 0.91 0.69

Quarterly Balance Sheets for Oppenheimer

This table presents Oppenheimer's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets		 2,856 2,920 3,092 2,975 3,252 3,263 3,367 3,572 3,687
Cash and Due from Banks		 37 30 29 31 28 33 32 37 38
Trading Account Securities		 758 831 1,000 943 1,142 1,156 1,157 1,314 1,400
Loans and Leases, Net of Allowance		 0.00 0.00 61 61 0.00 63 66 68 64
Loans and Leases		 - - 61 61 - 63 66 68 64
Customer and Other Receivables		 1,236 1,118 1,066 1,087 1,180 1,162 1,296 1,350 1,342
Premises and Equipment, Net		 34 38 43 43 41 40 38 37 35
Goodwill		 138 138 138 138 142 142 142 144 144
Intangible Assets		 32 32 32 32 170 34 34 36 35
Other Assets		 493 706 697 615 548 632 602 588 629
Total Liabilities & Shareholders' Equity		 2,856 2,920 3,092 2,975 3,252 3,263 3,367 3,572 3,687
Total Liabilities		 1,956 2,094 2,278 2,170 2,450 2,450 2,529 2,700 2,790
Short-Term Debt		 1,159 1,375 1,468 1,394 1,231 1,427 1,453 1,579 1,744
Other Short-Term Payables		 197 156 189 224 - 210 262 181 233
Long-Term Debt		 178 132 207 169 207 332 320 360 324
Other Long-Term Liabilities		 422 431 414 383 1,012 483 495 580 490
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 773 801 788 779 802 812 838 872 897
Total Preferred & Common Equity		 771 800 788 779 802 812 838 872 897
Total Common Equity		 771 800 788 779 802 812 838 872 897
Common Stock		 26 22 26 29 20 23 27 23 27
Retained Earnings		 744 777 762 751 781 789 811 849 868
Accumulated Other Comprehensive Income / (Loss)		 1.16 0.92 0.26 -0.32 0.53 -0.05 0.22 0.20 2.35

Annual Metrics And Ratios for Oppenheimer

This table displays calculated financial ratios and metrics derived from Oppenheimer's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.78% -8.49% -4.46% 7.29% -0.93% 8.33% 19.77% 17.01% -19.74% 12.41% 14.71%
EBITDA Growth		 -40.63% -57.79% -101.94% 10,430.39% 72.58% 48.37% 123.76% 27.15% -65.51% 6.61% 61.08%
EBIT Growth		 -60.85% -114.12% -801.65% 189.31% 129.49% 66.96% 125.60% 32.92% -79.72% 2.67% 126.12%
NOPAT Growth		 -80.67% -133.62% -801.65% 241.51% 33.23% 83.28% 132.26% 29.25% -79.80% -5.72% 135.36%
Net Income Growth		 -63.44% -69.69% -83.06% 4,546.84% 26.63% 83.28% 132.26% 29.25% -79.80% -5.72% 135.36%
EPS Growth		 -64.97% -77.42% -164.29% 2,322.22% 2.50% 86.34% 143.46% 25.81% -78.03% 0.78% 145.95%
Operating Cash Flow Growth		 2,383.90% -124.79% -244.43% 75.87% 1,144.68% -53.05% -168.31% 521.37% -71.69% -129.17% -475.06%
Free Cash Flow Firm Growth		 137.22% 35.07% 103.34% -146.62% 226.85% -79.82% -69.01% -1,377.82% 258.65% -160.69% -112.35%
Invested Capital Growth		 -4.43% -6.62% -14.97% 8.99% -7.68% 0.84% 5.91% 15.34% -8.75% 8.19% 16.38%
Revenue Q/Q Growth		 -6.87% -2.64% 0.25% 5.26% -5.90% 8.83% 13.08% -4.28% -3.15% 2.97% 11.49%
EBITDA Q/Q Growth		 -34.57% -37.92% 90.14% 137.99% -0.81% 0.69% 146.64% -14.00% -39.77% -9.12% -0.85%
EBIT Q/Q Growth		 -56.48% -133.60% 4.82% 551.55% -1.77% 34.94% 97.52% -10.54% -57.52% -21.01% -0.72%
NOPAT Q/Q Growth		 -75.31% -197.23% 4.82% 815.47% -30.57% 48.00% 98.61% -12.93% -55.78% -26.28% -1.20%
Net Income Q/Q Growth		 -53.31% -66.91% 152.51% 16,433.33% -30.62% 48.00% 98.61% -12.93% -55.78% -26.28% -1.20%
EPS Q/Q Growth		 -54.74% -74.07% -169.23% 1,328.57% -29.31% 48.64% 88.26% -12.03% -51.78% -24.05% -1.39%
Operating Cash Flow Q/Q Growth		 719.58% 23.03% -244.01% 79.12% 23.47% 8.14% 41.33% -0.75% 579.29% -129.68% 7.91%
Free Cash Flow Firm Q/Q Growth		 803.08% -9.26% 41.59% -223.31% 3,661.61% -88.05% 106.16% -32.00% 782.28% -56.76% -77.76%
Invested Capital Q/Q Growth		 -2.53% -2.17% -6.97% 7.92% -2.79% 14.43% 5.28% 5.13% -6.06% -4.01% 1.38%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 4.51% 2.08% -0.04% 4.06% 7.08% 9.69% 18.11% 19.68% 8.46% 8.02% 11.26%
EBIT Margin		 1.75% -0.27% -2.55% 2.12% 4.92% 7.58% 14.29% 16.23% 4.10% 3.75% 7.38%
Profit (Net Income) Margin		 0.97% 0.32% 0.06% 2.48% 3.17% 5.36% 10.40% 11.48% 2.89% 2.42% 4.97%
Tax Burden Percent		 55.62% -119.36% -2.24% 116.69% 64.39% 70.69% 72.77% 70.76% 70.49% 64.73% 67.37%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 70.59% 0.00% 0.00% -10.91% 35.61% 29.31% 27.23% 29.24% 29.51% 35.27% 32.63%
Return on Invested Capital (ROIC)		 0.21% -0.08% -0.76% 1.12% 1.48% 2.82% 6.34% 7.39% 1.46% 1.38% 2.90%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.45% 0.19% 0.29% 1.20% 1.48% 2.82% 6.34% 7.39% 1.46% 1.38% 2.90%
Return on Net Nonoperating Assets (RNNOA)		 1.59% 0.62% 0.85% 3.28% 3.92% 6.49% 12.90% 12.01% 2.16% 2.38% 5.79%
Return on Equity (ROE)		 1.80% 0.55% 0.09% 4.40% 5.40% 9.31% 19.24% 19.40% 3.62% 3.76% 8.69%
Cash Return on Invested Capital (CROIC)		 4.74% 6.78% 15.42% -7.49% 9.47% 1.98% 0.59% -6.85% 10.61% -6.48% -12.25%
Operating Return on Assets (OROA)		 0.60% -0.09% -0.89% 0.84% 1.92% 3.18% 6.53% 7.80% 1.58% 1.67% 3.38%
Return on Assets (ROA)		 0.33% 0.11% 0.02% 0.98% 1.24% 2.25% 4.75% 5.52% 1.12% 1.08% 2.28%
Return on Common Equity (ROCE)		 1.78% 0.54% 0.09% 4.39% 5.40% 9.31% 19.24% 17.86% 3.30% 3.70% 8.69%
Return on Equity Simple (ROE_SIMPLE)		 1.81% 0.56% 0.10% 4.36% 5.30% 8.93% 17.94% 19.31% 4.04% 3.84% 8.38%
Net Operating Profit after Tax (NOPAT)		 5.06 -1.70 -15 22 29 53 123 159 32 30 71
NOPAT Margin		 0.52% -0.19% -1.79% 2.36% 3.17% 5.36% 10.40% 11.48% 2.89% 2.42% 4.97%
Net Nonoperating Expense Percent (NNEP)		 -0.24% -0.27% -1.05% -0.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 79.89% 82.45% 83.46% 79.89% 81.47% 81.15% 77.39% 74.23% 79.77% 75.25% 76.79%
Operating Expenses to Revenue		 98.25% 100.27% 102.55% 97.88% 95.08% 92.42% 85.71% 83.77% 95.90% 96.25% 92.62%
Earnings before Interest and Taxes (EBIT)		 17 -2.43 -22 20 45 75 169 225 46 47 106
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 44 19 -0.36 37 65 96 214 272 94 100 161
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.47 0.36 0.40 0.57 0.54 0.52 0.53 0.68 0.57 0.53 0.78
Price to Tangible Book Value (P/TBV)		 0.70 0.54 0.60 0.84 0.78 0.73 0.70 0.85 0.72 0.69 0.98
Price to Revenue (P/Rev)		 0.25 0.21 0.24 0.32 0.32 0.31 0.31 0.40 0.40 0.34 0.46
Price to Earnings (P/E)		 28.23 95.58 0.00 13.07 10.11 5.82 2.94 3.51 13.90 13.97 9.23
Dividend Yield		 2.41% 3.15% 2.86% 1.93% 2.00% 1.91% 5.11% 3.48% 4.27% 1.48% 1.03%
Earnings Yield		 3.54% 1.05% 0.00% 7.65% 9.89% 17.19% 33.97% 28.47% 7.20% 7.16% 10.84%
Enterprise Value to Invested Capital (EV/IC)		 0.85 0.82 0.80 0.86 0.82 0.81 0.82 0.74 0.77 0.83 0.92
Enterprise Value to Revenue (EV/Rev)		 2.02 2.00 1.73 1.90 1.67 1.54 1.38 1.23 1.46 1.50 1.69
Enterprise Value to EBITDA (EV/EBITDA)		 44.69 95.82 0.00 46.83 23.64 15.88 7.64 6.23 17.23 18.74 15.02
Enterprise Value to EBIT (EV/EBIT)		 115.13 0.00 0.00 89.57 34.00 20.30 9.69 7.55 35.53 40.13 22.91
Enterprise Value to NOPAT (EV/NOPAT)		 391.44 0.00 0.00 80.76 52.80 28.72 13.32 10.67 50.41 62.00 34.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.27 0.00 0.00 0.00 9.05 19.22 0.00 7.45 25.10 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.44 11.68 4.77 0.00 8.28 40.89 142.06 0.00 6.93 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.38 3.16 2.62 2.87 2.43 2.18 1.91 1.42 1.56 1.88 2.11
Long-Term Debt to Equity		 0.39 0.47 0.58 0.61 0.39 0.25 0.30 0.20 0.14 0.14 0.30
Financial Leverage		 3.51 3.27 2.89 2.74 2.64 2.30 2.04 1.62 1.48 1.72 2.00
Leverage Ratio		 5.41 5.18 4.75 4.51 4.38 4.13 4.05 3.51 3.25 3.47 3.82
Compound Leverage Factor		 5.41 5.18 4.75 4.51 4.38 4.13 4.05 3.51 3.25 3.47 3.82
Debt to Total Capital		 77.19% 75.97% 72.37% 74.13% 70.83% 68.56% 65.66% 58.62% 60.96% 65.28% 67.86%
Short-Term Debt to Total Capital		 68.24% 64.57% 56.48% 58.47% 59.38% 60.63% 55.35% 50.21% 55.56% 60.33% 58.33%
Long-Term Debt to Total Capital		 8.95% 11.40% 15.89% 15.66% 11.45% 7.93% 10.31% 8.41% 5.40% 4.96% 9.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.26% 0.32% 0.14% 0.02% 0.00% 0.00% 0.00% 5.64% 1.25% 0.00% 0.00%
Common Equity to Total Capital		 22.55% 23.71% 27.49% 25.86% 29.17% 31.44% 34.34% 35.75% 37.80% 34.71% 32.14%
Debt to EBITDA		 40.79 88.80 -3,714.28 40.14 20.52 13.50 6.12 4.95 13.63 14.82 11.13
Net Debt to EBITDA		 38.93 85.41 -3,534.97 38.85 19.11 12.67 5.95 3.70 12.17 14.53 10.92
Long-Term Debt to EBITDA		 4.73 13.32 -815.34 8.48 3.32 1.56 0.96 0.71 1.21 1.12 1.56
Debt to NOPAT		 357.25 -976.64 -87.74 69.22 45.83 24.41 10.66 8.49 39.89 49.03 25.20
Net Debt to NOPAT		 340.95 -939.36 -83.50 66.99 42.69 22.91 10.37 6.34 35.60 48.08 24.74
Long-Term Debt to NOPAT		 41.42 -146.55 -19.26 14.62 7.41 2.82 1.67 1.22 3.53 3.72 3.54
Noncontrolling Interest Sharing Ratio		 1.08% 1.24% 0.93% 0.29% 0.03% 0.00% 0.00% 7.92% 8.80% 1.63% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 114 153 312 -145 184 37 12 -147 234 -142 -301
Operating Cash Flow to CapEx		 1,780.70% -329.65% -1,166.72% -287.58% 1,943.84% 789.53% -1,193.88% 2,755.03% 395.39% -110.28% -2,101.17%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 3.97 0.81 0.74 -14.95 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 3.63 1.73 -3.45 23.11 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 3.45 1.51 -3.74 22.27 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.34 0.33 0.35 0.39 0.39 0.42 0.46 0.48 0.39 0.45 0.46
Fixed Asset Turnover		 31.38 31.03 30.90 33.82 32.46 32.72 40.01 49.61 34.30 30.98 34.91
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,340 2,185 1,858 2,025 1,869 1,885 1,997 2,303 2,101 2,273 2,646
Invested Capital Turnover		 0.41 0.40 0.42 0.47 0.47 0.53 0.61 0.64 0.50 0.57 0.58
Increase / (Decrease) in Invested Capital		 -108 -155 -327 167 -155 16 111 306 -202 172 372
Enterprise Value (EV)		 1,979 1,791 1,488 1,751 1,526 1,521 1,638 1,697 1,619 1,877 2,423
Market Capitalization		 249 188 206 298 292 308 362 558 450 422 660
Book Value per Share		 $38.71 $38.57 $38.22 $39.94 $41.07 $46.31 $54.88 $65.25 $72.43 $76.06 $82.31
Tangible Book Value per Share		 $26.27 $25.94 $25.53 $27.00 $28.27 $33.03 $41.28 $51.78 $56.93 $59.05 $64.96
Total Capital		 2,340 2,185 1,858 2,025 1,869 1,885 1,997 2,303 2,101 2,273 2,646
Total Debt		 1,806 1,660 1,345 1,501 1,324 1,292 1,311 1,350 1,281 1,484 1,796
Total Long-Term Debt		 209 249 295 317 214 150 206 194 113 113 252
Net Debt		 1,724 1,597 1,280 1,453 1,233 1,213 1,276 1,008 1,143 1,455 1,762
Capital Expenditures (CapEx)		 4.40 5.89 5.73 5.61 8.67 10 4.53 8.27 16 17 5.15
Net Nonoperating Expense (NNE)		 -4.51 -4.60 -16 -1.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 1,806 1,660 1,345 1,501 1,324 1,292 1,311 1,350 1,281 1,484 1,796
Total Depreciation and Amortization (D&A)		 27 21 22 18 20 21 45 48 48 53 56
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.65 $0.14 $0.00 $0.00 $2.18 $4.10 $9.73 $12.57 $2.77 $2.81 $6.91
Adjusted Weighted Average Basic Shares Outstanding		 13.60M 13.64M 13.37M 13.25M 13.25M 12.90M 12.64M 12.64M 11.67M 10.74M 10.35M
Adjusted Diluted Earnings per Share		 $0.62 $0.14 ($0.09) $1.67 $2.05 $3.82 $9.30 $11.70 $2.57 $2.59 $6.37
Adjusted Weighted Average Diluted Shares Outstanding		 14.25M 14.29M 13.37M 13.67M 14.06M 13.85M 13.22M 13.58M 12.61M 11.65M 11.23M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $4.10 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.73M 13.41M 13.44M 13.24M 13.05M 13.09M 12.68M 12.42B 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 12 -1.70 -15 14 29 53 123 159 32 30 71
Normalized NOPAT Margin		 1.23% -0.19% -1.79% 1.49% 3.17% 5.36% 10.40% 11.48% 2.89% 2.42% 4.97%
Pre Tax Income Margin		 1.75% -0.27% -2.55% 2.12% 4.92% 7.58% 14.29% 16.23% 4.10% 3.75% 7.38%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.97 1.64 10.78 22.79 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.62 1.16 7.84 16.13 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.78 1.42 10.49 21.96 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.44 0.94 7.55 15.29 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 62.58% 207.32% 2,368.02% 36.31% 21.48% 11.23% 15.11% 12.23% 21.94% 21.31% 9.61%
Augmented Payout Ratio		 62.58% 491.99% 3,169.45% 69.02% 41.88% 27.09% 27.34% 17.10% 210.78% 137.34% 23.09%

Quarterly Metrics And Ratios for Oppenheimer

This table displays calculated financial ratios and metrics derived from Oppenheimer's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -9.95% 17.08% 23.60% 8.91% 3.72% 7.80% 6.89% 19.41% 23.32% 4.16% 12.88%
EBITDA Growth		 -59.49% 18.28% -74.17% 79.38% -23.81% 62.66% 1,964.09% 41.72% -4.32% 7.91% 55.54%
EBIT Growth		 -67.08% 34.03% -89.64% 198.25% -41.09% 96.62% 235.61% 63.85% -4.30% 10.47% 103.03%
NOPAT Growth		 -64.41% 47.92% -89.64% 195.37% -48.20% 77.99% 225.36% 77.86% -7.48% 19.08% 111.12%
Net Income Growth		 -64.41% 47.92% -102.71% 195.37% -48.20% 77.99% 207.30% 77.86% -7.48% 19.08% 111.12%
EPS Growth		 -60.13% 76.81% -165.63% 227.03% -44.81% 94.26% 208.24% 78.51% -8.91% 14.77% 107.61%
Operating Cash Flow Growth		 59.39% 43.39% 18.35% -55.09% -55.68% 8.22% -78.19% -82.83% 14.21% -16.06% 134.76%
Free Cash Flow Firm Growth		 192.03% 121.40% -58.18% -184.01% -171.66% -12.50% 76.93% -84.30% -125.35% -554.33% -423.97%
Invested Capital Growth		 -8.75% -4.95% 13.69% 5.88% 8.19% -3.99% 3.27% 10.20% 16.38% 25.49% 15.33%
Revenue Q/Q Growth		 13.81% 1.86% -6.42% 8.29% 8.39% 14.67% -7.21% 20.98% 11.94% -11.99% 1.46%
EBITDA Q/Q Growth		 115.88% -25.59% -95.43% 2,342.73% -8.31% 58.87% -41.99% 67.72% -38.09% 79.18% -16.39%
EBIT Q/Q Growth		 318.24% -37.07% -161.42% 284.52% -17.39% 110.03% -57.64% 122.94% -51.75% 142.43% -22.15%
NOPAT Q/Q Growth		 379.89% -35.39% -156.62% 268.26% -15.84% 121.99% -60.12% 138.73% -56.22% 185.72% -29.30%
Net Income Q/Q Growth		 379.89% -35.39% -166.15% 244.01% -15.84% 121.99% -60.12% 138.73% -56.22% 185.72% -29.30%
EPS Q/Q Growth		 394.59% -33.33% -169.67% 242.35% -16.53% 134.65% -61.18% 134.78% -57.41% 195.65% -29.78%
Operating Cash Flow Q/Q Growth		 -0.45% -158.35% 24.89% 202.93% -1.76% -220.84% -45.82% 109.92% 553.42% -222.79% 143.68%
Free Cash Flow Firm Q/Q Growth		 640.16% -39.33% -326.64% 61.77% -36.30% 174.08% -159.75% -205.47% -66.65% -49.36% 31.09%
Invested Capital Q/Q Growth		 -6.06% 11.03% 6.69% -4.86% -4.01% -1.47% 14.75% 1.53% 1.38% 6.24% 5.46%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 12.93% 10.19% 0.50% 11.23% 9.50% 15.37% 9.61% 13.32% 7.37% 15.00% 12.36%
EBIT Margin		 9.26% 6.17% -4.05% 6.90% 5.26% 11.26% 5.14% 9.47% 4.08% 11.25% 8.63%
Profit (Net Income) Margin		 6.85% 4.69% -3.31% 4.41% 3.42% 7.74% 3.33% 6.56% 2.57% 8.33% 5.81%
Tax Burden Percent		 73.95% 75.93% 81.78% 63.83% 65.03% 68.73% 64.71% 69.29% 62.86% 74.09% 67.29%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 26.05% 24.07% 0.00% 36.17% 34.97% 31.27% 35.29% 30.71% 37.14% 25.91% 32.71%
Return on Invested Capital (ROIC)		 3.46% 2.22% -1.44% 2.32% 1.95% 4.08% 1.61% 3.39% 1.50% 4.78% 3.13%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.46% 2.22% -1.53% 2.32% 1.95% 4.08% 1.61% 3.39% 1.50% 4.78% 3.13%
Return on Net Nonoperating Assets (RNNOA)		 5.13% 3.78% -2.63% 3.95% 3.36% 7.38% 3.40% 6.88% 2.99% 9.64% 7.00%
Return on Equity (ROE)		 8.58% 5.99% -4.07% 6.27% 5.31% 11.45% 5.01% 10.27% 4.49% 14.41% 10.13%
Cash Return on Invested Capital (CROIC)		 10.61% 6.61% -11.45% -3.93% -6.48% 5.89% -0.79% -6.81% -12.25% -19.59% -11.07%
Operating Return on Assets (OROA)		 3.58% 2.35% -1.60% 2.87% 2.35% 4.39% 1.98% 3.84% 1.87% 4.77% 3.70%
Return on Assets (ROA)		 2.64% 1.79% -1.31% 1.83% 1.53% 3.02% 1.28% 2.66% 1.18% 3.53% 2.49%
Return on Common Equity (ROCE)		 7.83% 5.46% -3.70% 5.70% 5.22% 11.27% 4.93% 10.10% 4.49% 14.41% 10.13%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 4.60% 4.05% 5.27% 0.00% 5.18% 7.56% 8.61% 0.00% 8.73% 9.76%
Net Operating Profit after Tax (NOPAT)		 22 14 -8.19 14 12 26 10 25 11 31 22
NOPAT Margin		 6.85% 4.69% -2.84% 4.41% 3.42% 7.74% 3.33% 6.56% 2.57% 8.33% 5.81%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 71.73% 79.29% 78.43% 75.34% 68.78% 78.82% 84.55% 74.67% 71.35% 73.21% 75.26%
Operating Expenses to Revenue		 90.74% 93.83% 104.05% 93.10% 94.74% 88.74% 94.86% 90.53% 95.92% 88.75% 91.37%
Earnings before Interest and Taxes (EBIT)		 30 19 -12 22 18 37 16 35 17 41 32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 42 31 1.44 35 32 51 30 50 31 55 46
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.57 533.75 0.55 0.51 0.53 0.52 0.61 0.63 0.78 0.72 0.77
Price to Tangible Book Value (P/TBV)		 0.72 677.67 0.70 0.65 0.69 0.85 0.78 0.80 0.98 0.91 0.96
Price to Revenue (P/Rev)		 0.40 377.37 0.37 0.33 0.34 0.34 0.40 0.41 0.46 0.43 0.46
Price to Earnings (P/E)		 13.90 11,339.47 13.56 9.60 13.97 9.96 8.05 7.35 9.23 8.24 7.91
Dividend Yield		 4.27% 1.96% 1.90% 1.99% 1.48% 1.51% 1.26% 1.23% 1.03% 1.16% 1.09%
Earnings Yield		 7.20% 0.01% 7.38% 10.42% 7.16% 10.04% 12.43% 13.61% 10.84% 12.13% 12.65%
Enterprise Value to Invested Capital (EV/IC)		 0.77 183.74 0.84 0.82 0.83 0.81 0.86 0.87 0.92 0.90 0.92
Enterprise Value to Revenue (EV/Rev)		 1.46 378.67 1.75 1.59 1.50 1.52 1.81 1.77 1.69 1.75 1.83
Enterprise Value to EBITDA (EV/EBITDA)		 17.23 4,338.66 21.99 17.52 18.74 15.23 14.98 13.94 15.02 15.30 14.97
Enterprise Value to EBIT (EV/EBIT)		 35.53 8,507.70 46.41 32.60 40.13 28.01 23.92 21.30 22.91 23.06 21.60
Enterprise Value to NOPAT (EV/NOPAT)		 50.41 11,650.80 65.16 47.01 62.00 43.93 36.14 31.46 34.00 33.22 31.09
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.10 3,284.70 14.35 30.46 0.00 0.00 0.00 0.00 0.00 0.00 78.96
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.93 2,709.31 0.00 0.00 0.00 13.55 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.56 1.82 2.06 1.94 1.88 1.79 2.17 2.12 2.11 2.22 2.31
Long-Term Debt to Equity		 0.14 0.16 0.25 0.21 0.14 0.26 0.41 0.38 0.30 0.41 0.36
Financial Leverage		 1.48 1.70 1.71 1.70 1.72 1.81 2.11 2.03 2.00 2.02 2.24
Leverage Ratio		 3.25 3.35 3.49 3.42 3.47 3.79 3.91 3.86 3.82 4.08 4.07
Compound Leverage Factor		 3.25 3.35 3.49 3.42 3.47 3.79 3.91 3.86 3.82 4.08 4.07
Debt to Total Capital		 60.96% 64.58% 67.28% 66.00% 65.28% 64.22% 68.41% 67.90% 67.86% 68.97% 69.75%
Short-Term Debt to Total Capital		 55.56% 58.93% 58.97% 58.87% 60.33% 54.97% 55.51% 55.65% 58.33% 56.18% 58.82%
Long-Term Debt to Total Capital		 5.40% 5.65% 8.31% 7.13% 4.96% 9.24% 12.90% 12.24% 9.53% 12.79% 10.92%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.25% 1.11% 1.05% 1.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 37.80% 34.31% 31.67% 32.91% 34.71% 35.78% 31.59% 32.10% 32.14% 31.03% 30.25%
Debt to EBITDA		 13.63 15.25 17.69 14.18 14.82 12.00 11.87 10.89 11.13 11.72 11.37
Net Debt to EBITDA		 12.17 14.68 17.11 13.67 14.53 11.77 11.65 10.69 10.92 11.50 11.16
Long-Term Debt to EBITDA		 1.21 1.33 2.19 1.53 1.12 1.73 2.24 1.96 1.56 2.17 1.78
Debt to NOPAT		 39.89 40.95 52.42 38.07 49.03 34.62 28.65 24.57 25.20 25.46 23.61
Net Debt to NOPAT		 35.60 39.43 50.70 36.68 48.08 33.95 28.10 24.13 24.74 24.97 23.18
Long-Term Debt to NOPAT		 3.53 3.58 6.48 4.11 3.72 4.98 5.40 4.43 3.54 4.72 3.70
Noncontrolling Interest Sharing Ratio		 8.80% 8.83% 9.02% 9.12% 1.63% 1.60% 1.60% 1.58% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 224 136 -308 -118 -161 119 -71 -217 -362 -540 -372
Operating Cash Flow to CapEx		 3,151.07% -2,439.05% -1,042.85% 2,433.66% 1,426.43% -30,638.76% -8,180.70% 5,197.27% 2,291.08% -5,457.47% 3,555.37%
Free Cash Flow to Firm to Interest Expense		 0.00 10.34 -17.63 0.00 0.00 5.79 -3.23 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 -6.55 -3.70 0.00 0.00 -3.85 -5.24 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -6.82 -4.06 0.00 0.00 -3.86 -5.31 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.39 0.38 0.39 0.42 0.45 0.39 0.39 0.41 0.46 0.42 0.43
Fixed Asset Turnover		 34.30 33.83 34.36 31.68 30.98 30.15 29.59 32.01 34.91 36.84 39.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,101 2,333 2,489 2,368 2,273 2,240 2,571 2,610 2,646 2,811 2,964
Invested Capital Turnover		 0.50 0.47 0.51 0.53 0.57 0.53 0.48 0.52 0.58 0.57 0.54
Increase / (Decrease) in Invested Capital		 -202 -121 300 132 172 -93 81 242 372 571 394
Enterprise Value (EV)		 1,619 428,703 2,082 1,930 1,877 1,825 2,218 2,268 2,423 2,530 2,722
Market Capitalization		 450 427,226 436 398 422 414 493 529 660 628 692
Book Value per Share		 $72.43 $72.16 $71.31 $73.86 $76.06 $76.65 $78.62 $81.09 $82.31 $82.87 $85.21
Tangible Book Value per Share		 $56.93 $56.83 $55.93 $57.75 $59.05 $46.76 $61.55 $64.03 $64.96 $65.85 $68.20
Total Capital		 2,101 2,333 2,489 2,368 2,273 2,240 2,571 2,610 2,646 2,811 2,964
Total Debt		 1,281 1,507 1,675 1,563 1,484 1,439 1,758 1,772 1,796 1,939 2,068
Total Long-Term Debt		 113 132 207 169 113 207 332 320 252 360 324
Net Debt		 1,143 1,451 1,620 1,506 1,455 1,411 1,725 1,740 1,762 1,902 2,030
Capital Expenditures (CapEx)		 4.68 3.53 6.20 2.74 4.59 0.26 1.41 0.22 3.26 1.68 1.13
Net Nonoperating Expense (NNE)		 0.00 0.00 1.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 1,281 1,507 1,675 1,563 1,484 1,439 1,758 1,772 1,796 1,939 2,068
Total Depreciation and Amortization (D&A)		 12 12 13 14 14 14 14 14 14 14 14
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.94 $1.32 ($0.85) $1.32 $1.02 $2.50 $0.99 $2.38 $1.04 $2.93 $2.06
Adjusted Weighted Average Basic Shares Outstanding		 11.67M 11.09M 11.02M 10.52M 10.74M 10.41M 10.33M 10.33M 10.35M 10.47M 10.52M
Adjusted Diluted Earnings per Share		 $1.83 $1.22 ($0.85) $1.21 $1.01 $2.37 $0.92 $2.16 $0.92 $2.72 $1.91
Adjusted Weighted Average Diluted Shares Outstanding		 12.61M 11.96M 11.02M 11.44M 11.65M 11.00M 11.11M 11.28M 11.23M 11.28M 11.35M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 22 14 -8.19 14 12 26 10 25 11 31 22
Normalized NOPAT Margin		 6.85% 4.69% -2.84% 4.41% 3.42% 7.74% 3.33% 6.56% 2.57% 8.33% 5.81%
Pre Tax Income Margin		 9.26% 6.17% -4.05% 6.90% 5.26% 11.26% 5.14% 9.47% 4.08% 11.25% 8.63%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 1.45 -0.67 0.00 0.00 1.82 0.72 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 1.10 -0.47 0.00 0.00 1.25 0.47 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 1.18 -1.02 0.00 0.00 1.81 0.66 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.83 -0.82 0.00 0.00 1.24 0.40 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 21.94% 18.54% 20.78% 15.87% 21.31% 15.29% 10.18% 9.06% 9.61% 9.41% 8.57%
Augmented Payout Ratio		 210.78% 149.44% 88.22% 94.58% 137.34% 111.13% 70.70% 27.76% 23.09% 11.13% 9.68%

Key Financial Trends

Oppenheimer (NYSE:OPY) has shown consistent financial performance and growth over the past four years based on its quarterly financial statements.

Positive Trends:

  • Increasing net income: The company's consolidated net income rose from a loss of $9.4 million in Q2 2023 to positive earnings of approximately $21.7 million in Q2 2025, reflecting an improvement in profitability.
  • Steady growth in total revenue: Total revenue grew from $288.7 million in Q2 2023 to $373.2 million in Q2 2025, indicating an expanding business base.
  • Investment banking income shows robust growth, increasing from $120.99 million in Q1 2024 to $169.16 million in Q2 2025, signaling strength in higher-margin service lines.
  • Non-interest income growth, especially trust fees and service charges, supporting diversification of revenue streams.
  • Consistent payment of dividends, with cash dividends per share increasing from $0.15 in Q2 2023 to $0.18 in Q2 2025, indicating shareholder return commitment.
  • Net cash from operating activities improved dramatically from -$64.7 million in Q2 2023 to $40.1 million in Q2 2025, showing better cash flow management and operational performance.
  • Stable balance sheet with total assets increasing from approximately $3.09 billion in Q2 2023 to $3.69 billion by Q2 2025, supporting ongoing growth.
  • Total common equity rose from $788 million in Q2 2023 to almost $897 million in Q2 2025, indicating strengthening shareholder equity.
  • Reduction in allowance for loan losses, with provisions turning positive in recent quarters, which could signal improving credit quality.

Neutral Factors:

  • Fluctuations in amortization and depreciation expenses stayed relatively consistent, reflecting ongoing investments in intangible and fixed assets.
  • Interest income has been fairly consistent at around $35-38 million per quarter, with no interest expenses reported in recent periods, suggesting low financing costs.
  • Shares outstanding have increased mildly from about 10.3 million basic shares in early 2023 to about 10.5-10.6 million in 2025 quarters, indicating small dilution or equity issuance.

Negative Trends:

  • Non-interest expense continues to rise, reaching $341 million in Q2 2025, up from about $301 million in Q2 2023, placing pressure on operating margins.
  • High cash income taxes paid in some quarters (e.g., $23.9 million in Q2 2025) impact free cash flow available for reinvestment or dividends.
  • Volatility in net cash from financing activities, with significant outflows in repurchase of common equity and dividends, which might constrain financial flexibility.
  • Significant short-term debt, close to $1.74 billion as of Q2 2025, which is more than 4.7 times the common equity, could raise liquidity or refinancing risks if not managed well.

In summary, Oppenheimer's financial statements show a company with improving profitability and revenues supported by strong investment banking income and diversified fee income. It has strengthened its equity base and improved operating cash flows in recent quarters. However, rising expenses and a high level of short-term debt highlight areas investors should monitor. The steady dividend increases and positive net income over the last year are encouraging signs for retail investors.

08/08/25 02:24 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Oppenheimer's Financials

When does Oppenheimer's fiscal year end?

According to the most recent income statement we have on file, Oppenheimer's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Oppenheimer's net income changed over the last 10 years?

Oppenheimer's net income appears to be on an upward trend, with a most recent value of $71.25 million in 2024, rising from $9.56 million in 2014. The previous period was $30.27 million in 2023.

How has Oppenheimer's revenue changed over the last 10 years?

Over the last 10 years, Oppenheimer's total revenue changed from $981.14 million in 2014 to $1.43 billion in 2024, a change of 46.0%.

How much debt does Oppenheimer have?

Oppenheimer's total liabilities were at $2.53 billion at the end of 2024, a 21.4% increase from 2023, and a 12.4% increase since 2014.

How much cash does Oppenheimer have?

In the past 10 years, Oppenheimer's cash and equivalents has ranged from $28.84 million in 2023 to $213.76 million in 2021, and is currently $33.15 million as of their latest financial filing in 2024.

How has Oppenheimer's book value per share changed over the last 10 years?

Over the last 10 years, Oppenheimer's book value per share changed from 38.71 in 2014 to 82.31 in 2024, a change of 112.6%.


Related Companies

This page (NYSE:OPY) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsored
How high will gold surge?
Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...
Weiss Ratings | Sponsored
Shocked one of my clients with this
Trump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...
Altimetry | Sponsored
Critical AI announcement set to ignite AI 2.0
While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...
Timothy Sykes | Sponsored
Trump’s new nightmare
According to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...
Porter & Company | Sponsored
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...
The Oxford Club | Sponsored